about
Non-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART eraHepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?Human immunodeficiency virus and liver disease forum 2010: conference proceedingsHIV infection enhances TRAIL-induced cell death in macrophage by down-regulating decoy receptor expression and generation of reactive oxygen species.Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen.Molecular mechanisms of liver fibrosis in HIV/HCV coinfectionTRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.Hepatitis C virus sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1-dependent pathwayHIV-1 tropism and liver fibrosis in HIV-HCV co-infected patientsPotent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins.HIV infection increases HCV-induced hepatocyte apoptosis.Effects of HCV on basal and tat-induced HIV LTR activationHBV and HIV co-infection: Impact on liver pathobiology and therapeutic approaches.HIV infection of hepatocytes results in a modest increase in hepatitis C virus expression in vitroCoinfection with HIV-1 and HCV--a one-two punch.The HIV matrix protein p17 promotes the activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2.The association of HIV viral load with indirect markers of liver injury.Immune restoration diseases reflect diverse immunopathological mechanisms.HIV/hepatitis B virus co-infection: current challenges and new strategies.Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionRetrospective Proteomic Analysis of Cellular Immune Responses and Protective Correlates of p24 Vaccination in an HIV Elite Controller Using Antibody Arrays.HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals.Modelling Hepatotoxicity of Antiretroviral Therapy in the Liver during HIV Monoinfection
P2860
Q26797897-79551436-CA5C-46D7-89CB-2AC9B3F25A36Q26798469-139B7FAC-4F41-4E88-8C63-1A57E0B50CC5Q28674930-506702C2-D0E0-42B0-AD90-5234612B9AEEQ33869186-7D822043-BAB3-464B-9081-6B80A5C0D79BQ33877464-8B39305E-4D57-4BEF-8BAC-372A4FEA9A6FQ33907429-DE6E2584-C5D6-49A1-A38B-C0CADBBB7DA8Q34081462-CB25E2C3-FDC0-4A4D-BF6A-958D8E24F06AQ34291165-7BC8B239-56FC-4CC3-A7B1-EC35CA22348FQ34505231-702125DE-2CEB-4C1C-9B11-DB35E9FE76D7Q34546374-29EBDC5A-1A7E-474D-8D07-10A6EFC881BAQ34699457-F86165F9-8F6F-4A04-B2CF-D80F08E86193Q34769530-6F6CAA35-934A-4754-83D4-B667BC152EEEQ34966832-F73493D5-D495-4ACD-AB2B-2F89B05FD959Q35105824-F35FE3AD-5BEA-47C8-A18F-9D1A855DBAB0Q35137038-E005D38C-1444-4F5D-8EC0-DD9DEAF51A92Q35149334-284D08BC-C629-4CF8-A749-0FD12083E54BQ35681714-DDE5B5E1-A821-4D9F-AEB2-C82A3CC7A3EDQ37409995-83439470-EBA3-417B-BD94-4FF95E127532Q37630062-1B873430-C155-41B1-A5DE-1B81AB6D3457Q38749963-8B324F7C-260A-488D-8019-3A600A961FA8Q40549933-BD50DE33-4BB6-4717-8E10-F06BC7200F9BQ40627202-DA8FC267-62FE-4400-AD57-349B8F99933DQ59050627-CB32249F-66BD-413E-8A0B-77316882081E
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
HIV induces TRAIL sensitivity in hepatocytes
@ast
HIV induces TRAIL sensitivity in hepatocytes
@en
type
label
HIV induces TRAIL sensitivity in hepatocytes
@ast
HIV induces TRAIL sensitivity in hepatocytes
@en
prefLabel
HIV induces TRAIL sensitivity in hepatocytes
@ast
HIV induces TRAIL sensitivity in hepatocytes
@en
P2093
P2860
P1433
P1476
HIV induces TRAIL sensitivity in hepatocytes
@en
P2093
Challagundla K Babu
Gary D Bren
Kanitta Suwansrinon
Stacey A Rizza
P2860
P356
10.1371/JOURNAL.PONE.0004623
P407
P577
2009-02-27T00:00:00Z